Leuprorelin acetate Prescribing at CENTRAL SURGERY
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
142
Total Quantity
142
NHS Cost
£22.0K
vs National Avg
+206.4%
CENTRAL SURGERY prescribed 142 items of Leuprorelin acetate over the last 12 months at a cost of £22,015 to the NHS. This is 206.4% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jun 2026
16
Jun 2026
12
Jun 2026
12
Jun 2026
31
Jun 2026
9
Jun 2026
13
Jun 2026
25
Jun 2026
8
Jun 2026
16
Prescribing Details
| Total Items | 142 |
|---|---|
| Total Quantity | 142 |
| Total NHS Cost | £22,015 |
| Presentations | 2 different forms |
| vs National Average | +206.4% |
Leuprorelin acetate Prescribing Comparison
| This practice | 142 items |
|---|---|
| National average per practice | 46 items |
| Difference | +206.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.